Workflow
a
icon
搜索文档
Casella Waste Systems, Inc. Announces Remarketing of Finance Authority of Maine Solid Waste Disposal Revenue Bonds
Globenewswire· 2025-07-18 04:05
RUTLAND, Vt., July 17, 2025 (GLOBE NEWSWIRE) -- Casella Waste Systems, Inc. (“Casella”) (NASDAQ:CWST), a regional solid waste, recycling and resource management services company, today announced that it has commenced the remarketing of $29.0 million aggregate principal amount of Finance Authority of Maine (the “Issuer”) Solid Waste Disposal Revenue Bonds (Casella Waste Systems, Inc. Project) Series 2015R-1 issued on August 27, 2015 and Series 2015R-2 issued on April 2, 2018 (collectively, the “Bonds”). The ...
Bank OZK Announces Record Second Quarter 2025 Earnings
Globenewswire· 2025-07-18 04:05
LITTLE ROCK, Ark., July 17, 2025 (GLOBE NEWSWIRE) -- Bank OZK (the “Bank”) (Nasdaq: OZK) today announced that net income available to common stockholders for the second quarter of 2025 was a record $178.9 million, a 3.1% increase from $173.5 million for the second quarter of 2024. For the first six months of 2025, net income available to common stockholders was $346.8 million, a 0.5% increase from $345.0 million for the first six months of 2024. Diluted earnings per common share ("EPS") for the second quart ...
Rocket Companies to Announce Second Quarter 2025 Results on July 31, 2025
Prnewswire· 2025-07-18 04:05
DETROIT, July 17, 2025 /PRNewswire/ -- Rocket Companies, Inc. (NYSE: RKT) ("Rocket Companies" or the "Company"), the Detroit-based fintech platform including mortgage, real estate, title and personal finance businesses, today announced that the Company will issue its second quarter 2025 earnings on July 31, 2025. Leadership will host a conference call to discuss results at 4:30 p.m. ET on that date and a press release detailing the Company's results will be issued prior to the call.A live webcast of the eve ...
Exagen Inc. Appoints Chas McKhann to Board of Directors
Globenewswire· 2025-07-18 04:05
CARLSBAD, Calif., July 17, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of innovative autoimmune testing solutions, announced today the appointment of Chas McKhann to its Board of Directors, effective July 17, 2025. Mr. McKhann is an accomplished leader with over 25 years of experience in the life sciences industry, including Board and C-suite positions leading turnaround and transformational growth at multiple medical technology companies. Most recently, Mr. McKhann served as Boar ...
The RealReal Announces Timing of Its Second Quarter 2025 Earnings Conference Call
Globenewswire· 2025-07-18 04:05
SAN FRANCISCO, July 17, 2025 (GLOBE NEWSWIRE) -- The RealReal (Nasdaq: REAL)—the world’s largest online marketplace for authenticated, resale luxury goods—today announced that it will release its financial results for the second quarter, ended June 30, 2025, after the market closes on August 7, 2025. The RealReal will host a conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to review its financial results. A live webcast of the conference call will be available online at investor.therealrea ...
Great Southern Bancorp(GSBC) - 2025 Q2 - Earnings Call Transcript
2025-07-18 04:02
Great Southern Bancorp (GSBC) Q2 2025 Earnings Call July 17, 2025 03:00 PM ET Company ParticipantsJeff Tryka - Managing DirectorJoseph Turner - Director, President & CEORex Copeland - SVP, CFO & TreasurerDamon Delmonte - Managing DirectorJohn Rodis - Director - Banks & ThriftsOperatorGood day, and thank you for standing by. Welcome to the Great Southern Bancorp, Inc. Second Quarter twenty twenty five Earnings Conference Call. At this time, all participants are in a listen only mode. After the speakers' pres ...
Credit Acceptance Named 2025 Top Workplace in Financial Services
Globenewswire· 2025-07-18 04:02
Southfield, Michigan, July 17, 2025 (GLOBE NEWSWIRE) -- Credit Acceptance Corporation (Nasdaq: CACC) (referred to as the “Company”, “Credit Acceptance”, “we”, “our”, or “us”) has been named a 2025 Top Workplace in Financial Services for the second consecutive year. We ranked #4 in the 1,000+ employee size category, up five spots from last year. “Our goal is to create a workplace where team members love coming to work because they know they can make a difference,” said Ken Booth, Chief Executive Officer, Cre ...
TEM Shares Surge on New AI Breakthrough: Should Investors Jump In?
ZACKS· 2025-07-18 04:01
Key Takeaways Tempus AI gained FDA clearance for its ECG-Low EF tool, expanding its cardiology AI portfolio. A $200M deal with AZN and Pathos boosts TEM's role in building a major oncology foundation model. Hereditary testing revenue hit $63.5M, up 23% in volumes after Ambry Genetics' integration.Tempus AI (TEM) jumped 7.3% at yesterday’s close after securing FDA 510(k) clearance for its ECG-Low EF software, its second greenlighted AI tool in cardiology. The approval adds fuel to a stock already rallying ...
Talen Energy Expands and Enhances Portfolio with Best-in-Class CCGT Acquisitions in PJM
Globenewswire· 2025-07-18 04:01
HOUSTON, July 17, 2025 (GLOBE NEWSWIRE) -- Talen Energy Corporation (“Talen,” “we,” or “our”) (NASDAQ: TLN), a leading independent power producer, announced it has signed definitive agreements to acquire Caithness Energy’s Moxie Freedom Energy Center (“Moxie”) in Pennsylvania and Caithness Energy and BlackRock’s Guernsey Power Station (“Guernsey”) in Ohio, both combined-cycle gas-fired plants located within the PJM power market. The net acquisition price is $3.5 billion after adjusting for estimated tax ben ...
Updated Data from Eledon Pharmaceuticals' Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation to be Presented at the World Transplant Congress 2025
Globenewswire· 2025-07-18 04:01
IRVINE, Calif., July 17, 2025 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced that updated clinical data from its ongoing open-label Phase 1b study evaluating tegoprubart for the prevention of rejection in subjects undergoing kidney transplantation will be presented at the World Transplant Congress (WTC) taking place in San Francisco from August 2-6, 2025. The oral presentation will feature updated results from approximately 30 kidney transplant recipients and will ...